# EDGAR Filing Document

**Accession Number:** 0002075320
**File Stem:** 9999999995-26-000339
**Filing Date:** 2026-1
**Character Count:** 1359
**Document Hash:** b5f993cfd585f7b088c99ab9009a7ba2
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**9999999995-26-000339.hdr.sgml**: 20260130

**ACCESSION NUMBER**: 9999999995-26-000339

**CONFORMED SUBMISSION TYPE**: EFFECT

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20260129

**DATE AS OF CHANGE**: 20260130

**EFFECTIVENESS DATE**: 20260129

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Polaryx Therapeutics, Inc.
- **CENTRAL INDEX KEY:** 0002075320
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000
- **STATE OF INCORPORATION:** WY
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** EFFECT
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 333-291681
- **FILM NUMBER:** 26580279

**BUSINESS ADDRESS:**
- **STREET 1:** 140 EAST RIDGEWOOD AVENUE
- **STREET 2:** SUITE 415, SOUTH TOWER
- **CITY:** PARAMUS
- **STATE:** NJ
- **ZIP:** 07652
- **BUSINESS PHONE:** 201-940-7236

**MAIL ADDRESS:**
- **STREET 1:** SOUTH TOWER, 140 E RIDGEWOOD AVENUE
- **STREET 2:** SUITE 415
- **CITY:** PARAMUS
- **STATE:** NJ
- **ZIP:** 07652

### UNITED STATES
### SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## Notice of Effectiveness

**Date:** January 29, 2026

**Time:** 16:00:00

**Form Type:** S-1

---

**CIK:** 0002075320

**Company Name:** Polaryx Therapeutics, Inc.

**File Number:** 333-291681